ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Lyell Immunopharma Inc

Lyell Immunopharma Inc (LYEL)

1.51
-0.07
(-4.43%)
Closed July 02 3:00PM
1.51
0.00
( 0.00% )
Pre Market: 4:43AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 36.91M1.25M49.6M1.35M596k317k654k1.09M
Operating Income -37.26M-66.44M-14.78M-62.56M-65.91M-59.04M-59.51M-55.58M
Pre Tax Income -36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M-60.67M
Net Income -36.32M-70.25M-8.4M-66.96M-63.89M-50.85M-52.93M-60.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -37.28M-67.48M-12.9M-61.46M-66.23M-57.46M-60.01M-54.49M
EBITDA -33.09M-61.82M-9.74M-57.53M-60.84M-53.94M-54.45M-50.55M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 657k17.19M12.97M89.44M2.92M
Operating Income -102.09M-211.94M-214.78M-187.06M-247.01M
Pre Tax Income -129.38M-204.47M-250.22M-183.12M-234.63M
Net Income -129.38M-204.47M-250.22M-183.12M-234.63M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -11.571-13.132-1.031-0.734-0.932
EBIT -137.5M-210.41M-214.94M-185.17M-245.16M
EBITDA -100.83M-207.64M-201.28M-169.04M-226.76M